Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Common Equity (2020 - 2025)

Beauty Health (SKIN) has disclosed Common Equity for 6 consecutive years, with $61.1 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 17.86% to $61.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.1 million through Dec 2025, up 17.86% year-over-year, with the annual reading at $61.1 million for FY2025, 17.86% up from the prior year.
  • Common Equity for Q4 2025 was $61.1 million at Beauty Health, down from $65.7 million in the prior quarter.
  • The five-year high for Common Equity was $345.4 million in Q2 2022, with the low at -$142.1 million in Q3 2021.
  • Average Common Equity over 5 years is $109.6 million, with a median of $67.4 million recorded in 2024.
  • The sharpest move saw Common Equity plummeted 605620.03% in 2021, then skyrocketed 2049.38% in 2022.
  • Over 5 years, Common Equity stood at $298.0 million in 2021, then tumbled by 43.95% to $167.1 million in 2022, then crashed by 64.45% to $59.4 million in 2023, then dropped by 12.77% to $51.8 million in 2024, then increased by 17.86% to $61.1 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $61.1 million, $65.7 million, and $74.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.